First Manhattan Co. Sells 79,933 Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)

First Manhattan Co. lessened its holdings in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) by 7.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,025,654 shares of the biotechnology company’s stock after selling 79,933 shares during the quarter. First Manhattan Co. owned […]

Related Keywords

Manhattan ,New York ,United States ,Sanfordc Bernstein ,Piper Sandler ,Christopher Richard Anzalone ,Belpointe Asset Management ,Advisors Asset Management Inc ,Exchange Commission ,Quarter For Arrowhead Pharmaceuticals ,Arrowhead Pharmaceuticals ,First Manhattan Co ,Sumitomo Mitsui Financial Group ,Arrowhead Pharmaceuticals Inc ,Nasdaq ,Quadrant Capital Group ,Arrowhead Pharmaceuticals Stock Performance ,News Ratings For Arrowhead Pharmaceuticals Daily ,First Manhattan ,Get Rating ,Asset Management ,Ivy Capital Management ,Capital Group ,Captrust Financial Advisors ,Financial Advisors ,Richard Anzalone ,Director Douglas ,Mitsui Financial Group ,Visit Holdingschannel ,Arrowhead Pharmaceuticals Daily ,